Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Editas Medicine, Inc. (EDIT) had Return on Tangible Equity of -566.74% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.83M |
|
$-24.98M |
|
-- |
|
$2.83M |
|
$27.83M |
|
$-25.00M |
|
$0.02M |
|
$-24.98M |
|
$-24.98M |
|
$-24.98M |
|
$-24.98M |
|
$-24.98M |
|
$-24.98M |
|
$-25.00M |
|
$-24.52M |
|
97.88M |
|
97.88M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$128.07M |
|
$2.88M |
|
$21.27M |
|
$149.34M |
|
$39.78M |
|
-- |
|
$105.15M |
|
$144.93M |
|
$4.41M |
|
$4.41M |
|
$4.41M |
|
97.90M |
|
| Cash Flow Statement Financials | |
$-23.06M |
|
$0.06M |
|
-- |
|
$149.31M |
|
$126.32M |
|
$-23.00M |
|
$2.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-883.19% |
|
-883.19% |
|
-- |
|
-882.44% |
|
-882.44% |
|
$-23.00M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.09 |
|
82.40 |
|
-566.73% |
|
|
Return on Tangible Equity |
-566.74% |
-16.73% |
|
-566.74% |
|
$0.04 |
|
$-0.23 |
|
$-0.24 |
|